Skip to content

A study to test the effectiveness of Amrutprabha Gutika in treating allergic rhinitis.

Randomized controlled clinical trial to evaluate efficacy of Amrutprabha gutika in the management of Pratishayay with special reference to allergic rhinitis - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092694
Enrollment
60
Registered
2025-08-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

None listed

Sponsors

Dr Vaishnavi Ranganath Patil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients fulfilling clinical features of Pratishayay 2.selection of patients will be irrespective of their sex, religion, socioeconomic status

Exclusion criteria

Exclusion criteria: 1. Patients having any congenital deformity 2. Patients having nasal polyp, sinusitis, rhinorrhea due to foreign body or trauma, DNS 3. Patients having lower respiratory tract infection

Design outcomes

Primary

MeasureTime frame
Amrutprabha gutika is effective in the management of PratishayayTimepoint: Initial assessment at 0 day Follow up at 3rd day and 5th day Final assessment at 7th day

Secondary

MeasureTime frame
Amrutprabha gutika is effective than tablet levocetirizine in the management of PratishayayTimepoint: Initial assessment at 0 day Follow up at 3rd day and 5th day Final assessment at 7th day

Countries

India

Contacts

Public ContactDr Asmita Sudhir Yesane

Late Kedari Redekar Ayurvedic Mahavidyalaya Gadhinglaj

shindeasmita1982@gmail.com9552635237

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026